🔖
Cite This Article
Wiwanitkit, V., Mungmunpuntipantip, R. (2022). ICU admission and favipiravir. İstanbul Kuzey Klinikleri, Cilt: 8 - Sayı: 5, 544–544. https://ajindex.com/articles/551234
Journals / İstanbul Kuzey Klinikleri / 2021 / Cilt: 8 - Sayı: 5
ICU admission and favipiravir
- Journal
- İstanbul Kuzey Klinikleri
- Pages
- 544–544
- Publication Date
- 2022-10-18
- DOI
- —
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗References (2)
- Guner AE, Surmeli A, Kural K, Yilmaz H, Kocayigit E, Sahin E, et al. ICU admission rates in Istanbul following the addition of favipiravir to the national COVID-19 treatment protocol. North Clin Istanb 2021;8:119–23
- Guner R, Hasanoglu I, Kayaaslan B, Aypak A, Akinci E, Bodur H, et al. Comparing ICU admission rates of mild/moderate COVID-19 patients treated with hydroxychloroquine, favipiravir, and hydroxychloroquine plus favipiravir. J Infect Public Health 2021;14:365–70.